Annual Non Current Assets
$177.47 M
+$5.29 M+3.07%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual long term assets is $177.47 million, with the most recent change of +$5.29 million (+3.07%) on December 31, 2024.
- During the last 3 years, TVTX annual non current assets has fallen by -$16.30 million (-8.41%).
- TVTX annual non current assets is now -16.87% below its all-time high of $213.48 million, reached on December 31, 2018.
Performance
TVTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$177.47 M
-$2.25 M-1.25%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly long term assets is $177.47 million, with the most recent change of -$2.25 million (-1.25%) on December 1, 2024.
- Over the past year, TVTX quarterly non current assets has increased by +$5.29 million (+3.07%).
- TVTX quarterly non current assets is now -24.10% below its all-time high of $233.81 million, reached on June 30, 2016.
Performance
TVTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TVTX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | +3.1% |
| 3 y3 years | -8.4% | +3.1% |
| 5 y5 years | +1.0% | +3.1% |
TVTX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +3.1% | -12.7% | +21.0% |
| 5 y | 5-year | -9.9% | +3.1% | -12.7% | +21.0% |
| alltime | all time | -16.9% | -100.0% | -24.1% | -100.0% |
Travere Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $416.70 M(-32.4%) | - |
| Dec 2024 | - | $177.47 M(-1.3%) |
| Sep 2024 | - | $179.72 M(-1.4%) |
| Jun 2024 | - | $182.19 M(-0.2%) |
| Mar 2024 | - | $182.52 M(+6.0%) |
| Dec 2023 | $616.77 M(+26.8%) | $172.19 M(+17.4%) |
| Sep 2023 | - | $146.67 M(-24.5%) |
| Jun 2023 | - | $194.34 M(-4.4%) |
| Mar 2023 | - | $203.33 M(+9.2%) |
| Dec 2022 | $486.44 M(-16.5%) | $186.19 M(-2.7%) |
| Sep 2022 | - | $191.34 M(-0.7%) |
| Jun 2022 | - | $192.68 M(-2.3%) |
| Mar 2022 | - | $197.31 M(+1.8%) |
| Dec 2021 | $582.83 M(+42.0%) | $193.77 M(-1.1%) |
| Sep 2021 | - | $196.00 M(-0.5%) |
| Jun 2021 | - | $196.97 M(-1.0%) |
| Mar 2021 | - | $199.00 M(+1.0%) |
| Dec 2020 | $410.41 M(-4.3%) | $197.03 M(+1.3%) |
| Sep 2020 | - | $194.54 M(+12.4%) |
| Jun 2020 | - | $173.13 M(+4.0%) |
| Mar 2020 | - | $166.43 M(-5.3%) |
| Dec 2019 | $429.06 M(-13.4%) | $175.74 M(+0.9%) |
| Sep 2019 | - | $174.10 M(-8.6%) |
| Jun 2019 | - | $190.56 M(-0.8%) |
| Mar 2019 | - | $192.16 M(-10.0%) |
| Dec 2018 | $495.68 M | $213.48 M(+0.1%) |
| Sep 2018 | - | $213.20 M(+0.5%) |
| Jun 2018 | - | $212.23 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $213.99 M(+10.0%) |
| Dec 2017 | $325.81 M(-2.0%) | $194.54 M(-0.3%) |
| Sep 2017 | - | $195.17 M(+4.1%) |
| Jun 2017 | - | $187.47 M(-0.3%) |
| Mar 2017 | - | $187.98 M(-2.6%) |
| Dec 2016 | $332.35 M(+10.1%) | $192.93 M(+1.6%) |
| Sep 2016 | - | $189.83 M(-18.8%) |
| Jun 2016 | - | $233.81 M(+11.7%) |
| Mar 2016 | - | $209.36 M(-0.5%) |
| Dec 2015 | $301.93 M(+708.7%) | $210.33 M(-0.6%) |
| Sep 2015 | - | $211.68 M(+17.3%) |
| Jun 2015 | - | $180.40 M(-1.1%) |
| Mar 2015 | - | $182.45 M(+85.9%) |
| Dec 2014 | $37.33 M(+397.7%) | $98.14 M(-2.3%) |
| Sep 2014 | - | $100.49 M(-1.6%) |
| Jun 2014 | - | $102.14 M(+16.6%) |
| Mar 2014 | - | $87.61 M(+574.0%) |
| Dec 2013 | $7.50 M(>+9900.0%) | $13.00 M(+187.8%) |
| Sep 2013 | - | $4.52 M(+99.1%) |
| Jun 2013 | - | $2.27 M(-1.9%) |
| Mar 2013 | - | $2.31 M(>+9900.0%) |
| Dec 2012 | $33.20 K(+751.3%) | - |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | - | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Feb 2012 | $3900.00(-2.5%) | - |
| Nov 2011 | - | $0.00(0.0%) |
| Feb 2011 | $4000.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual long term assets?
- What is the all time high annual non current assets for Travere Therapeutics?
- What is Travere Therapeutics annual non current assets year-on-year change?
- What is Travere Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Travere Therapeutics?
- What is Travere Therapeutics quarterly non current assets year-on-year change?
What is Travere Therapeutics annual long term assets?
The current annual non current assets of TVTX is $177.47 M
What is the all time high annual non current assets for Travere Therapeutics?
Travere Therapeutics all-time high annual long term assets is $213.48 M
What is Travere Therapeutics annual non current assets year-on-year change?
Over the past year, TVTX annual long term assets has changed by +$5.29 M (+3.07%)
What is Travere Therapeutics quarterly long term assets?
The current quarterly non current assets of TVTX is $177.47 M
What is the all time high quarterly non current assets for Travere Therapeutics?
Travere Therapeutics all-time high quarterly long term assets is $233.81 M
What is Travere Therapeutics quarterly non current assets year-on-year change?
Over the past year, TVTX quarterly long term assets has changed by +$5.29 M (+3.07%)